Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Whady Hueb

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Circulation|September 12, 2012
Effect of complete revascularization on 10-year survival of patients with stable multivessel coronary artery disease: MASS II trialRicardo D'Oliveira Vieira, Whady Hueb, Bernard J Gersh, et al.
Medicine|August 20, 2015
Role of Trimetazidine in Ischemic Preconditioning in Patients With Symptomatic Coronary Artery DiseaseLeandro M A Costa, Paulo C Rezende, Rosa M R Garcia, et al.
American Heart Journal|October 17, 2012
The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entrySameer Bansilal, Michael E Farkouh, Whady Hueb, et al.
Aging|August 25, 2021
Effect of diabetic kidney disease on therapeutic strategies for coronary artery disease: ten year follow-upDaniel Valente Batista, Whady Hueb, Eduardo Gomes Lima, et al.
Diabetology & Metabolic Syndrome|July 9, 2024
Unveiling myocardial microstructure shifts: exploring the impact of diabetes in stable CAD patients through CMR T1 mappingGustavo André Boeing Boros, Whady Hueb, Paulo Cury Rezende, et al.
European Heart Journal|July 6, 2013
Long-term analysis of left ventricular ejection fraction in patients with stable multivessel coronary disease undergoing medicine, angioplasty or surgery: 10-year follow-up of the MASS II trialCibele Larrosa Garzillo, Whady Hueb, Bernard J Gersh, et al.
International Journal of Cardiology|August 1, 2006
Quality of life in patients with symptomatic multivessel coronary artery disease: a comparative post hoc analyses of medical, angioplasty or surgical strategies-MASS II trialMaria Elenita Favarato, Whady Hueb, William E Boden, et al.
International Journal of Molecular Sciences|December 23, 2023
High-Sensitivity Troponin I and Cardiovascular Events in Stable Coronary Artery Disease: Insights from a Longitudinal Outpatient StudyCelia Maria Cassaro Strunz, Whady Hueb, Paulo Cury Rezende, et al.
Journal of Cardiothoracic Surgery|September 4, 2021
Surgical and percutaneous revascularization outcomes based on SYNTAX I, II, and residual scores: a long-term follow-up studyEduardo Bello Martins, Whady Hueb, David L Brown, et al.
Circulation|September 15, 2010
Five-year follow-up of a randomized comparison between off-pump and on-pump stable multivessel coronary artery bypass grafting. The MASS III TrialWhady Hueb, Neuza H Lopes, Alexandre C Pereira, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Circulation|September 12, 2012
Effect of complete revascularization on 10-year survival of patients with stable multivessel coronary artery disease: MASS II trialRicardo D'Oliveira Vieira, Whady Hueb, Bernard J Gersh, et al.
Medicine|August 20, 2015
Role of Trimetazidine in Ischemic Preconditioning in Patients With Symptomatic Coronary Artery DiseaseLeandro M A Costa, Paulo C Rezende, Rosa M R Garcia, et al.
American Heart Journal|October 17, 2012
The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entrySameer Bansilal, Michael E Farkouh, Whady Hueb, et al.
Aging|August 25, 2021
Effect of diabetic kidney disease on therapeutic strategies for coronary artery disease: ten year follow-upDaniel Valente Batista, Whady Hueb, Eduardo Gomes Lima, et al.
Diabetology & Metabolic Syndrome|July 9, 2024
Unveiling myocardial microstructure shifts: exploring the impact of diabetes in stable CAD patients through CMR T1 mappingGustavo André Boeing Boros, Whady Hueb, Paulo Cury Rezende, et al.
European Heart Journal|July 6, 2013
Long-term analysis of left ventricular ejection fraction in patients with stable multivessel coronary disease undergoing medicine, angioplasty or surgery: 10-year follow-up of the MASS II trialCibele Larrosa Garzillo, Whady Hueb, Bernard J Gersh, et al.
International Journal of Cardiology|August 1, 2006
Quality of life in patients with symptomatic multivessel coronary artery disease: a comparative post hoc analyses of medical, angioplasty or surgical strategies-MASS II trialMaria Elenita Favarato, Whady Hueb, William E Boden, et al.
International Journal of Molecular Sciences|December 23, 2023
High-Sensitivity Troponin I and Cardiovascular Events in Stable Coronary Artery Disease: Insights from a Longitudinal Outpatient StudyCelia Maria Cassaro Strunz, Whady Hueb, Paulo Cury Rezende, et al.
Journal of Cardiothoracic Surgery|September 4, 2021
Surgical and percutaneous revascularization outcomes based on SYNTAX I, II, and residual scores: a long-term follow-up studyEduardo Bello Martins, Whady Hueb, David L Brown, et al.
Circulation|September 15, 2010
Five-year follow-up of a randomized comparison between off-pump and on-pump stable multivessel coronary artery bypass grafting. The MASS III TrialWhady Hueb, Neuza H Lopes, Alexandre C Pereira, et al.
Pageof 10